-
FDA approves gout treatment from Savient
WASHINGTON The Food and Drug Administration has approved a new treatment for gout, a painful condition that affects 3 million adults in the United States.
The FDA announced the approval of Savient Pharmaceuticals’ Krystexxa (pegloticase), a biotech drug for people who have not responded to or tolerated conventional therapies.
-
Safeway offering Fluzone High-Dose to seniors
PLEASANTON, Calif. Safeway on Tuesday announced that all Safeway pharmacies in the United States now have a new high-dose flu vaccine called Fluzone High-Dose, which has been approved by the Food and Drug Administration for use in people 65 years of age and older.